A Safe & Effective Solution For Diagnosed Skin Conditions
Phothera is the leading manufacturer of FDA-cleared narrowband home phototherapy devices for chronic skin conditions, with more than 80 years of experience helping patients take steps to treat their chronic skin conditions.
Phototherapy for Chronic Skin Conditions
Narrowband ultraviolet B (NB-UVB) phototherapy is a first-line treatment for psoriasis, vitiligo, and Cutaneous T-cell lymphoma (CTCL), and an important treatment option for eczema (atopic dermatitis) when topical or biologic therapies are not enough.
Phothera helps make this treatment available both at home and in your doctor’s office.
Different conditions. One trusted treatment that fits your life.
Phototherapy, the Way It Should Be Prescribed
Phothera delivers clinically studied phototherapy devices designed to support both at-home treatment and in-office settings to best fit your needs.
At-Home Phototherapy
- Prescribed by your dermatologist and designed for safe home treatment
- Enabled with the ClearLink® Controller with Guided Mode technology designed to support safe, accurate, and effective treatment
- Up to 3x higher treatment completion rates compared with standard home phototherapy. (LITE Study, n=783)1
- Convenient and easy to fit into daily life
- Broad insurance coverage with $0 cost for eligible patients*
*$0 patient cost applies to eligible insured patients. Not all patients will qualify.
Phototherapy Administered in Office
- Covered by most major insurance providers
- Clinical phototherapy solutions designed for multiple chronic skin conditions and treatment areas
- National dermatology treatment guidelines recommended
The same proven narrowband UVB therapy.
Delivered where it works best for you.
Phototherapy & lifestyle changes have helped me regain control of my life.
– Karen
Your Path Forward
Learn if at-home phototherapy options are right for you.
See the science behind Phothera & our at-home devices.
References:
- Gelfand JM, Armstrong AW, Lim HW, et al. JAMA Dermatol. 2024; doi:10.1001/jamadermatol.2024.3897
EMA is a registered trademark of Modernizing Medicine, Inc. Epic is a registered trademark of Epic Systems Corporation.